Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Omega Healthcare Investors (OHI)

Omega Healthcare raises 2024 AFFO guidance as Q3 net income rises to $115 million

Positive Impact 4 of 5 earnings Written later

Omega Healthcare Investors reported third quarter 2024 results, with revenue of $276.0 million, up $34.0 million from a year earlier, and net income of $114.9 million, or $0.42 per diluted share, compared with $0.37 in the third quarter of 2023. The company raised its full-year 2024 Adjusted FFO guidance to $2.84 to $2.86 per diluted share from $2.78 to $2.84.

Key points

  • Q3 2024 net income $114.9 million, or $0.42 per diluted share, versus $93.9 million, or $0.37, in Q3 2023
  • Q3 2024 revenue $276.0 million, up $34.0 million year over year
  • Q3 2024 Adjusted FFO $203.1 million, or $0.74 per common share, versus $182.2 million, or $0.71, in Q3 2023
  • 2024 Adjusted FFO guidance raised to $2.84 to $2.86 per diluted share from $2.78 to $2.84; quarterly dividend of $0.67 per share payable November 15, 2024

The filing

CompanyOmega Healthcare Investors (OHI)
Form8-K, current report
Filed with the SECOct 30, 2024, 4:23 PM ET
Accession number0000888491-24-000041

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.